J&J (NYSE: JNJ) said to offer hip case accord which may exceed $2B
- Stock futures lower as countdown to Yellen speech begins
- St. Jude Medical (STJ) Mentioned as Short at Muddy Waters
- Mylan's (MYL) Steps on EpiPen Do Not Go Far Enough - Wells Fargo's Maris
- Amazon (AMZN) Announces Car Research Destination Amazon Vehicles
- Bank of America (BAC) at an Inflection Point - Goldman Sachs
Johnson & Johnson (NYSE: JNJ) said to offer hip case accord which may exceed $2 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Lowers Remicade Outlook for Johnson & Johnson (JNJ); Affirms 'Neutral' Rating
- ON Semiconductor (ON) Agrees to Divest IGBT Business as Part of Fairchild Semi (FCS) Acquisition - FTC
- Drug price hikes can damage company reputations: White House
Create E-mail Alert Related CategoriesGeneral News, Litigation
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!